Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.

With advanced orthopaedic and cartilage-care infrastructure, Apollo Hospital offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 1983, the JCI hospital is located in Chennai, India, and has 550 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Fortis Hospital offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2004, the NABH, NABL hospital is located in Noida, India, with 400 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
Manipal Hospital, Yeshwantpur offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2022, the JCI, NABH, NABL hospital is situated in Bangalore, India, with 250 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
BGS Gleneagles Global Hospitals offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2007, the NABH, NABL hospital is located in Bangalore, India, with 500 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
nM Virani Wockhardt offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 1998, the NABH hospital is situated in Rajkot, India, with 280 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
With advanced orthopaedic and cartilage-care infrastructure, Medical Park Gebze Hospital offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 2015, the JCI hospital is located in Kocaeli, Turkey, and has 120 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Manipal Hospital, Dwarka provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 2018, the NABH hospital is based in Delhi, India, with 380 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
Guven Hospital offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 1975, the GHA hospital is situated in Ankara, Turkey, with 254 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
Dr. Rela Institute and Medical Centre provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 2018, the NABH, NABL hospital is based in Chennai, India, with 450 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
At Quironsalud Marbella Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 1979, the ISO hospital is located in Marbella, Spain, and has 120 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
Srikara Hospital, RTC Cross Roads offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2013, the NABH hospital is situated in Hyderabad, India, with 120 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
Yatharth hospital provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 2008, the JCI, NABH, NABL hospital is based in Delhi, India, with 400 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
At Vinmec Phu Quoc Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2015, the JCI hospital is located in Phu Quoc, Vietnam, and has 150 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
Vinmec Times City provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 2012, the JCI hospital is based in Ha noi, Vietnam, with 500 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
With advanced orthopaedic and cartilage-care infrastructure, Casa di Cura La Madonnina offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 1958, the SSN hospital is located in milan, Italy, and has 560 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.